Thornhill J A, Walsh A, Kelly D, Fennelly J J, Fitzpatrick J M
Irish Testicular Tumour Registry, Dublin, Ireland.
Eur Urol. 1988;15(1-2):84-8. doi: 10.1159/000473402.
All non-seminomatous germ cell testis cancer in Ireland (1980-1985) was analysed (n = 131) and 3-year survival was: stage I = 95% (n = 58), stage II = 54% (n = 36), stages III and IV = 24% (n = 34). Countrywide results were not as favourable as those achieved in specialist units and this supports the development of a national strategy to maximise disease control. No management protocols existed during this study and the variety of approaches helped to identify the most suitable types of treatment in this broad context.
对爱尔兰所有非精原细胞瘤性睾丸癌患者（1980 - 1985年，n = 131）进行了分析，其3年生存率为：I期95%（n = 58），II期54%（n = 36），III期和IV期24%（n = 34）。全国范围内的结果不如专科单位取得的结果理想，这支持制定一项国家战略以最大程度地控制疾病。在本研究期间不存在管理方案，各种治疗方法有助于在这一广泛背景下确定最合适的治疗类型。
